Supplementary Data from The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER<sup>+</sup> Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor ResistanceMandy Lawson,Natalie Cureton,Susana Ros,Azadeh Cheraghchi-Bashi,Jelena Urosevic,Sophie D'Arcy,Oona Delpuech,Michelle DuPont,David I. Fisher,Eric T. Gangl,Hilary Lewis,Dawn Trueman,Neha Wali,Stuart C. Williamson,Jennifer Moss,Elodie Montaudon,Heloise Derrien,Elisabetta Marangoni,Ricardo J. Miragaia,Sladjana Gagrica,Pablo Morentin-Gutierrez,Thomas A. Moss,Gareth Maglennon,Daniel Sutton,Radoslaw Polanski,Alan Rosen,Jonathan Cairns,Pei Zhang,Mònica Sánchez-Guixé,Violeta Serra,Susan E. Critchlow,James S. Scott,Justin P.O. Lindemann, Simon T. Barry,Teresa Klinowska,Christopher J. Morrow,Larissa S. Carnevallicrossref（2024）引用 0|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
